Top 10 MS Australia News Stories of 2023
5 January 2024
As we take our first steps into 2024, let’s take a moment to look back at ten of the biggest MS Australia news stories from 2023.
As we take our first steps into 2024, let’s take a moment to look back at ten of the biggest MS Australia news stories from 2023.
The International Progressive MS Alliance is funding two major initiatives to tackle the pressing demand for new and effective treatments for people living with progressive MS.
Lived experience experts and researchers come together in Perth for MS Australia’s biennial conference.
MS Australia is delighted to launch TrialSmart, a new educational series for people living with MS exploring different aspects of clinical trials. Australia is about to embark on several new groundbreaking clinical trials in MS, including PLATYPUS. TrialSmart provides the background and information to enable empowered choices for people with MS.
New clinical trial investigated individuals with progressive MS experiencing cognitive difficulties, and the potential impact of cognitive rehabilitation and exercise.
CEO Rohan Greenland reflects on the key milestones MS Australia has achieved in 2023 detailing the significant progress made in several strategically important areas.
Ken’s MS diagnosis arrived like an unwelcome guest but inspired him to ensure that no one with MS feels alone. Now, he leaves a legacy to accelerate MS cure efforts and provide care.
The Pharmaceutical Benefits Advisory Committee (PBAC) has announced its recommendations for subsidised access to shingles vaccine Shingrix® for people aged 18 years and over at a moderate to high risk of infection, including some people living with MS.
The latest findings from the EVOLUTION trials indicated that evobrutinib did not achieve its main goal of reducing relapse rates over up to 156 weeks, when compared to teriflunomide in both studies.